Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "f hoffmann la roche ltd"

ImmuNext Enters into a Strategic Alliance to Develop Novel Therapies for Autoimmune Diseases

ImmuNext Enters into a Strategic Alliance to Develop Novel The...

ImmuNext, Inc., today announced that it has entered into an agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (Roche) focused on the development of novel therapeutics that modulate the immune system for the treatment of inflammation ... Financial Buzz, 4 weeks ago

4 images for f hoffmann la roche ltd

Nasdaq, 1 month ago
Treasury Today, 6 months ago
Treasury Today, 6 months ago
Swiss Biotech, 6 months ago


Studies from F. Hoffmann-La Roche Describe New Findings in Organic Research [Practical Synthesis of MDM2 Antagonist RG7388. Part 2: Development of the Cu(I) Catalyzed [3+2] Asymmetric Cycloaddition Process for the Manufacture of Idasanutlin] By a ...
 4 Traders5 days ago

31P and 1H NMR Studies of the Molecular Organization of Lipids in the Parallel Artificial Membrane Permeability Assay

† Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Innovation Center Basel, F. Hoffmann-La Roche Ltd. , Grenzacherstrasse 124, 4070 Basel, Switzerland ∥ Roche Pharmaceutical Research and Early Development, ...
 Molecular Pharmaceutics1 month ago

CHUGAI PHARMACEUTICAL : Anti-Influenza Drug, Tamiflu Filed for Additional Dosage and Administration for Newborns and Infants by Public Knowledge-Based Application

Release date- 16122016 - TOKYO- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it has filed public knowledge-based applications for anti-influenza drug 'Tamiflu Dry Syrup 3%' (oseltamivir phosphate) for the dosage and ...
 4 Traders4 weeks ago Chugai files public knowledge-based applications for Tamiflu to treat influenza A/B virus to newborns and infants  PharmaBiz1 month ago
Pharmaceutical Business Review

Roche's emicizumab haemophilia drug succeeds in phase III trial

A phase 3 clinical trial assessing Roche's emicizumab haemophilia drug in patients 12 years old and older met its primary endpoint. Patients receiving emicizumab showed a statistically significant reduction in bleeds over time compared with those ...
 Pharmaceutical Business Review3 weeks ago
PR Newswire

Europe $792 Million Continuous Glucose Monitoring Systems Market by Component, Demographics and Adult Population and End User - Global Opportunity Analysis and Industry Forecast, 2014-2022 - Research and Markets

Research and Markets has announced the addition of the "Europe Continuous Glucose Monitoring Systems Market by Component, Demographics and Adult Population and End User - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ...
 4 Traders6 hours ago Increasing Demand for Self Administration & Home Care - Research and Markets  Wallstreet Online8 hours ago Urinalysis Market 2016-2022: By Product Type (Consumables, Biochemical Urine Analyzers), Test Type (Biochemical, Microscopic), Application (UTI, Diabetes) & End-User (Hospitals, Clinical Laboratories) - Research and Markets  Benzinga.com9 hours ago Drug Delivery Technology Market by Route of Administration & Patient Care Setting - Global Forecast to 2021 - Research and Markets  4 Traders11 hours ago
Diagnostic & Invasive Cardiology

Point-of-care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

LONDON, Jan. 17, 2017 /PRNewswire/ -- Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt ...
 TickerTech.com3 hours ago Urinalysis Market - Rise in Geriatric Population Single-Handedly Driving Demand for Urinalysis  Digital Journal1 day ago Imaging Biomarkers Market to Drive Growth Across Asia Pacific 2024  Digital Journal4 days ago Hepatitis C Diagnosis and Treatment Market Dynamics, Top Players Analysis, Trend and Forecast To 2022  Before It's News4 days ago
Broadway World

Smart Medical Devices Market to be Worth US$66.1 Billion by 2024: Awareness About Disease Management Lures Consumers Toward Sophisticated Products, Notes TMR

Transparency Market Research states that the leading players operating in theGlobal Smart Medical Devices Marketheld a huge share of 43% in 2015. Apple Inc., F.Hoffmann-La Roche Ltd., and Abbott Laboratories have been frontrunners in the overall ...
 International Business Times1 day ago Global Smart Medical Devices Market Is Expected to Be Worth US$66.1 Bn by 2024 & Regional Outlook  Digital Journal2 hours ago Global mHealth Monitoring and Diagnostic Medical Devices Market Exhibiting an Enormous 43.30% CAGR by 2019, Rising Shipments of Smart Devices  Digital Journal6 days ago

BUYINS.NET: THG, CCOI, HALO, ANW, PODD, FLY Are Seasonally Ripe To Go Up In the Next Five Weeks

(M2 PRESSWIRE via COMTEX) -- BUYINS.NET / is monitoring the Seasonality of The Hanover Insurance Group (NYSE:THG), Cogent Communications Group Inc (NASDAQ:CCOI), Halozyme Therapeutics Inc. (NASDAQ:HALO), Aegean Marine Petroleum ...
 TradingCharts.com1 day ago

Belhaj & Anor v Straw & Ors [2017] UKSC 3 (17 January 2017)

Hilary Term [2017] UKSC 3 On appeals from: [2014] EWCA Civ 1394 and [2014] EWHC 3846 (QB) JUDGMENT Belhaj and another (Respondents) v Straw and others (Appellants) Rahmatullah (No 1) (Respondent) v Ministry of ...
 Bailii.org15 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less